Company: NMP
Filing Date: 2025-04-09
Form Type: DRS/A
Source: 0001213900-25-030132
Chunk: 98

Company: NMP Acquisition Corp.
Filing Date: 2025-04-09
Form: DRS/A
Chunk 98
---
 and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. The personal and financial interests of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our shareholders’ best interest. If this were the case, it may be a breach of their fiduciary duties to us as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders’ rights. See the section titled “ Description of Securities — Certain Differences in Corporate Law — Shareholders’ Suits” for further information on the ability to bring such claims. However, we might not ultimately be successful in any claim we may make against them for such reason. 65 Since our sponsor, officers and directors, and any other persons who have an interest in our founder shares and/or private placement units, including any non-managing sponsor members, will lose their entire investment in us , except to the extent they are entitled to redeem any public shares they acquire , as described in this prospectus, or to receive liquidating distributions on the founder shares from assets outside the trust account, if our initial business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. On January 13, 2025, our sponsor acquired 3,833,333 founder shares for a purchase price of $25,000, or approximately $0.0065 per share. As of the date of this filing, there were 3,833,333 Class B ordinary shares issued to our sponsor, of which an aggregate of up to 500,000 Class B ordinary shares are subject to forfeiture to the extent that the underwriters’ over -allotmentoption is not exercised in full or in part so that the number of founder shares will equal 25% of the aggregate of our issued and outstanding Class A and Class B ordinary shares after this offering (excluding private placement shares and representative shares). Prior to this offering, our sponsor may transfer founder shares, to our three independent director nominees for their board service, for nominal cash consideration. The founder shares will represent 25% of our issued and outstanding shares after this offering (